Exelixis
EXEL
#1634
Rank
C$13.75 B
Marketcap
$49.13
Share price
-5.75%
Change (1 day)
53.36%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $70.00 CAD on 2000-07-26

Lowest end of day price: $1.83 CAD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$51.92-6.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
$73.88-4.83%๐Ÿ‡ซ๐Ÿ‡ท France
$115.79-5.70%๐Ÿ‡บ๐Ÿ‡ธ USA
$78.60-3.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$418.41-4.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$217.80-4.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.65-5.43%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.75-7.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.32 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA